Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. Lopez-Corral
Results of a Prospective Phase II Trial With Ofatumumab as Part of Reduced Intensity Conditioning Regimen in High-Risk Non-Hodgkin B Lymphoma Patients: A GELTAMO Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (With Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Dose-Escalated Radioimmunotherapy as Part of Reduced Intensity Conditioning for Allogeneic Transplantation in Patients With Advanced High-Grade Non-Hodgkin Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Long-Term Outcome of Patients With Relapsed/Refractory B-Cell Non- Hodgkin Lymphoma Treated With Bispecific Antibody Blinatumomab in a Phase I Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Bendamustine as Part of Conditioning Regimen for Autologous Stem-Cell Transplantation in Patients With Aggressive Lymphomas: Final Analysis of a Phase 2 Study From Geltamo
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Nitroglycerin as a Radiosensitizer in Non-Small Cell Lung Cancer: Results of a Prospective Imaging-Based Phase II Trial
Clinical and Translational Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
A PHASE 2 CLINICAL TRIAL OF RITUXIMAB AND Β-Glucan PGG IN RELAPSED/REFRACTORY INDOLENT B-Cell NON-HODGKIN LYMPHOMA
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A Phase II Study of Bendamustine in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-Follicular Non-Hodgkin Lymphoma
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Evaluation of Bone Marrow Infiltration by Multidimensional Flow Cytometry in Patients With Diffuse Large B-Cell Lymphoma: Sub-Study of a Phase 2 Geltamo Clinical Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Combination of Chidamide With Choep Regimen in Previously Untreated Patients With Peripheral T-Cell Lymphoma: A Prospective, Multicenter, Single-Arm, Phase 1b/2 Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
